10208 Results

People

  1. Gonen
    Gonen
  2. Vickers
    Vickers
  3. Panageas
    Panageas
  4. Patil
    Patil
  5. Schultz
    Schultz
  6. Giralt
    Giralt
  7. Zhang
    Zhang
  8. Jarnagin
    Jarnagin
  9. Heller
    Heller
  10. D'Angelica
    D'Angelica

Groups

  1. Epidemiology and Biostatistics (10208)
  2. Biostatistics Service (6565)
  3. Department of Medicine (4908)
  4. Population Sciences Research Program (4867)
  5. Surgery (3680)
  6. Survivorship Research (3598)
  7. Solid Tumor Oncology Division (3294)
  8. GSK Faculty (2808)
  9. Center for Pancreatic Cancer Research (2495)
  10. Health Outcomes Research Group (2069)
  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (6429)
  2. Meeting Abstract (3246)
  3. Editorial (116)
  4. Review (93)
  5. Research Letter (80)
  6. Correspondence (77)
  7. Conference Paper (54)
  8. Miscellaneous (52)
  9. Book Section (43)
  10. Guidelines (13)
  11. Book Whole (5)
Groups
  1. Epidemiology and Biostatistics (10208)
  2. Biostatistics Service (6565)
  3. Department of Medicine (4908)
  4. Population Sciences Research Program (4867)
  5. Surgery (3680)
  6. Survivorship Research (3598)

More Groups

People
  1. Mithat Gonen (1028)
  2. Andrew Vickers (880)
  3. Sean Devlin (601)
  4. Katherine Panageas (512)
  5. Sujata Patil (511)
  6. Nikolaus Schultz (486)

More People

Years
  1. 2025 (210)
  2. 2024 (622)
  3. 2023 (692)
  4. 2022 (732)
  5. 2021 (610)
  6. 2020 (625)

More Years

Publications
  1. Journal of Clinical Oncology (1374)
  2. Blood (534)
  3. Annals of Surgical Oncology (462)
  4. Cancer Research (274)
  5. International Journal of Radiation Oncology, Biology, Physics (258)
  6. Clinical Cancer Research (250)

More Publications

Publishers
  1. American Society of Clinical Oncology (1487)
  2. Elsevier Inc. (1206)
  3. Springer (925)
  4. American Association for Cancer Research (761)
  5. Elsevier Science, Inc. (685)
  6. American Society of Hematology (601)

More Publishers

Results (10208)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic value of FDG PET/CT-based metabolic tumor volumes in metastatic triple negative breast cancer patients
    Journal Article

    Marinelli, B.; Espinet-Col, C.; Ulaner, G. A.; McArthur, H. L.; Gonen, M.; Jochelson, M.; Weber, W. A.
    American Journal of Nuclear Medicine and Molecular Imaging (2016)

    Fulltext@MSK | Save
  • Burden of surgical complications: Contribution of long-term costs by Clavien-Dindo classification
    Meeting Abstract

    Widmar, M.; Strombom, P.; Keskin, M.; Gennarelli, R. L.; Elkin, E.; Weiser, M. R.; Paty, P. B.; Smith, J. J.; Nash, G. M.; Garcia-Aguilar, J. E.
    Journal of the American College of Surgeons (2016)

    Fulltext@MSK | Save
  • Prospective phase II trial of combination hepatic artery and systemic chemotherapy for unresectable colorectal liver metastases: Long-term results and curative potential
    Meeting Abstract

    Ma, L. W.; Kemeny, N. E.; Capanu, M.; Chou, J.; Cercek, A.; Kingham, T. P.; Allen, P. J.; DeMatteo, R. P.; Jarnagin, W. R.; D'Angelica, M. I.
    Journal of the American College of Surgeons (2016)

    Fulltext@MSK | Save
  • Impact of AR-V7 protein localization in the prediction of therapeutic benefit of taxanes over androgen receptor signaling inhibitors (ARSi) in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Scher, H.; Graf, R.; Schreiber, N.; Lu, D.; Louw, J.; Alvarez, H. A. V.; Bambury, R.; Danila, D.; McLaughlin, B.; Heller, G.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Phase Ib/II open-label study of Ad-RTS-hIL-12 + veledimex gene therapy in chemotherapy-responsive locally advanced or metastatic breast cancer patients
    Meeting Abstract

    McArthur, H.; Page, D.; Proverbs-Singh, T.; Solomon, S.; Hudis, C.; Norton, L.; Patil, S.; Henrich, M.; Halpenny, D.; Erinjeri, J.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Phase I/II trial of palbociclib in combination with bicalutamide for the treatment of androgen receptor (AR)(+) metastatic breast cancer (MBC): Pharmacokinetics (PK)
    Meeting Abstract

    Gucalp, A.; Corben, A.; Patil, S.; Boyle, L. A.; Hudis, C.; Traina, T. A.
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M.; Goldfarb, S.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Tuvy, Y.; Bouvier, N.; Riches, J.; Kundra, R.; Ku, G.; Hechtman, J. F.; Kelsen, D.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with metastatic colorectal cancer (CRC) harboring NRAS mutations
    Meeting Abstract

    Braghiroli, M. I.; Chou, J. F.; Hechtman, J. F.; Capanu, M.; Cercek, A.; Yaeger, R.
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Functional characterization of a chr13q22.1 pancreatic cancer risk locus reveals long-range interaction and allele-specific effects on DIS3 expression
    Journal Article

    Hoskins, J. W.; Ibrahim, A.; Emmanuel, M. A.; Manmiller, S. M.; Wu, Y.; O'Neill, M.; Jia, J.; Collins, I.; Zhang, M.; Thomas, J. V.; more...
    Human Molecular Genetics (2016)

    Fulltext@MSK | Save